As the COVID-19 vaccine becomes more readily available, a conversation between you and your clinical team may assist with decisions regarding the use of vaccines approved under EUA for the prevention of COVID-19 by pregnant patients. Important considerations include:
- the level of activity of the virus in the community
- the potential efficacy of the vaccine
- the risk and potential severity of maternal disease, including the effects of disease on the fetus and newborn
- the safety of the vaccine for the pregnant patient and the fetus.
For the most up-to-date information and resources visit The American College American College of Obstetricians and Gynecologists here.
Meet our Doctors & Nurse Practitioners

Andrea Garland,
MD, MPH, FACOG
Dina M. Canavero,
MD, MPH, FACOG
Jacqueline Ho,
MD, FACOG
Blake R. Lambourne,
MD, FACOG
David H. Scates,
MD, FACOG
Denise L. Sweeney,
MD, FACOG
Richard J. Leach,
MD, FACOG
Analisa Marki,
MD, FACOG
Lia Walther, NP Announces Retirement,
NP
Jessica Beckmeyer, NP on a sabbatical from her NP career to raise her two boys.,

Maria Rivera,
MSN, FNP
Allison Della Maggiora,
RN, MSN, FNP-C
Adrienne Navarro,
WHNP